A. Orem Et Al. , "The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis," CLINICA CHIMICA ACTA , vol.284, no.1, pp.81-88, 1999
Orem, A. Et Al. 1999. The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis. CLINICA CHIMICA ACTA , vol.284, no.1 , 81-88.
Orem, A., Cimsit, G., Deger, O., Orem, C., & Vanizor, B., (1999). The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis. CLINICA CHIMICA ACTA , vol.284, no.1, 81-88.
Orem, ASIM Et Al. "The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis," CLINICA CHIMICA ACTA , vol.284, no.1, 81-88, 1999
Orem, ASIM Et Al. "The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis." CLINICA CHIMICA ACTA , vol.284, no.1, pp.81-88, 1999
Orem, A. Et Al. (1999) . "The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis." CLINICA CHIMICA ACTA , vol.284, no.1, pp.81-88.
@article{article, author={ASIM ÖREM Et Al. }, title={The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis}, journal={CLINICA CHIMICA ACTA}, year=1999, pages={81-88} }